Diane Havlir

Datos Biográficos

ID8929563
NOMBREDiane Havlir
NOMBRESDiane
APELLIDOHavlir
FIRMAHAVLIR D
AFILIACIONESUniversity of California, San Francisco
VERIFICADONo
TOTAL DE OBRAS14
TOTAL DE CITAS0
TOTAL COMO AUTOR14
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2011
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Exploring HIV risk perception mechanisms among youth in a test-and-treat trial in Kenya and Uganda

    Open AccessLawrence Owino, Jason Johnson-Peretz et al.ARTICLEPLOS Global Public Health2024

    Understanding risk perception and risk-taking among youth can inform targeted prevention efforts. Using a health beliefs model-informed framework, we analysed 8 semi-structured, gender-specific focus group discussions with 93 youth 15–24 years old (48% male, 52% female), drawn from the SEARCH trial in rural Kenya and Uganda in 2017–2018, coinciding with the widespread introduction of PrEP. Highly connected social networks and widespread uptake of…

  • Population-level viremia predicts HIV incidence at the community level across the Universal Testing and Treatment Trials in eastern and southern Africa

    Open AccessJoseph Larmarange, Pamela Bachanas et al.ARTICLEPLOS Global Public Health2023

    Universal HIV testing and treatment (UTT) strategies aim to optimize population-level benefits of antiretroviral treatment. Between 2012 and 2018, four large community randomized trials were conducted in eastern and southern Africa. While their results were broadly consistent showing decreased population-level viremia reduces HIV incidence, it remains unclear how much HIV incidence can be reduced by increasing suppression among people living with…

  • High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community

    Open AccessJamie Naso, Susy Rojas et al.ARTICLEHealth Equity2021

    Purpose: To understand vaccine attitudes of Latinx parents highly impacted by COVID-19. Methods: In April 2021, we surveyed parents about their attitudes for COVID-19 vaccination of their children at a community-based outdoor testing/vaccination site serving predominantly low-income Latinx persons in San Francisco. Results: Among 1033 parents (75% Latinx), 92% would “definitely” or “probably” vaccinate their children. Vaccine concerns were higher…

  • HIV retesting and risk behaviors among high-risk, HIV-uninfected adults in Uganda

    Open AccessKara Marson, Alex Ndyabakira et al.ARTICLEAIDS Care2021

    There are limited data characterizing HIV retesting among high-risk adults in sub-Saharan Africa. From October-December 2018, we distributed recruitment cards offering health evaluations with HIV testing at venues frequented by individuals at-risk of HIV infection in Southwest Uganda. Those who attended were asked about their HIV testing history and risk factors: having >1 sexual partner, an HIV+ partner, STIs, and/or transactional sex. We define…

  • Examining the Impact of the Golden Compass Clinical Care Program for Older People with HIV

    Open AccessJudy Y Tan, Mott Greene et al.ARTICLEAIDS and Behavior2021

    The combined burden of geriatric conditions, comorbidities, and HIV requires a model of HIV care that offers a comprehensive clinical approach with people 50 years or older with HIV. Golden Compass is an outpatient, multidisciplinary HIV-geriatrics program with an onsite HIV geriatrician, cardiologist, pharmacist, and social worker, offering specialist referrals, care navigation, and classes on improving functional status and cognition. Participa…

  • Leveraging incentives to increase HIV testing uptake among men

    Open AccessAlex Ndyabakira, Monica Getahun et al.ARTICLEBMC Public Health2019

    Registered with ClinicalTrials.gov on 08/10/2016, ID: NCT02890459. The first participant was enrolled on 11th April 2016

  • Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals

    Open AccessLinda-Gail Bekker, George A O Alleyne et al.ARTICLEThe Lancet2018

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S Cohen, Ying Qing Chen et al.ARTICLENew England Journal of Medicine2016

    BACKGROUND: An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. ART was then offered to all patients with HIV-1 infection (index participants). The study included more than 5 years of follow-up to assess the durability of such therapy for …

  • “How can I tell?” Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial

    Open AccessIrene Maeri, Alison El Ayadi et al.ARTICLEAIDS Care2016

    People living with HIV/AIDS anticipate HIV-related stigma and fear disclosure to intimate partners. Yet, disclosure is critical to reducing HIV transmission and improving care engagement. This qualitative study characterized HIV disclosure experiences and normative beliefs among couples in communities participating in an HIV test-and-treat trial in Kenya and Uganda (Sustainable East Africa Research in Community Health, NCT#01864603). In-depth int…

  • Men “missing” from population-based HIV testing

    Open AccessCarol S Camlin, Emmanuel Ssemmondo et al.ARTICLEAIDS Care2016

    Men's uptake of HIV testing is critical to the success of "test and treat" strategies in generalized epidemics. This study sought to identify cultural factors and community processes that influence men's HIV testing uptake in the baseline year of an ongoing test-and-treat trial among 334,479 persons in eastern Africa (SEARCH, NCT#01864603). Data were collected using participant observation at mobile community health campaigns (CHCs) (n = 28); foc…

  • Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial

    Open AccessHarsha Thirumurthy, Aleksandra Jakubowski et al.ARTICLEAIDS Care2016

    Expectations about future health and longevity are important determinants of individuals' decisions to invest in physical and human capital. Few population-level studies have measured subjective expectations and examined how they are affected by scale-up of antiretroviral therapy (ART). We assessed these expectations in communities receiving annual HIV testing and universal ART. Longitudinal data on expectations were collected at baseline and one…

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection

    Open AccessBeatriz Gilda Jegerhorn Grinsztejn, Beatriz Grinsztejn et al.ARTICLEThe Lancet Infectious Diseases2014

  • I Have Remained Strong Because of That Food”

    Open AccessSera Lewise Young, Barnabas Natamba et al.ARTICLEAIDS and Behavior2014

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S Cohen, Ying Qing Chen et al.ARTICLENew England Journal of Medicine2011

    BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic m…